Topics
Glioblastoma | Treatment | Immunotherapy | Bispecific antibody armed T cells
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Bispecific antibody armed T cells
Fadul CE, Thakur A, Kim J, Kassay-McAllister J, Schalk D, Lopes
MB, Donahue J, Purow B, Dillon P, Le T, Schiff D, Liu Q, Lum
LG.
Phase I study targeting newly
diagnosed grade 4 astrocytoma with bispecific antibody armed T
cells (EGFR BATs) in combination with radiation and
temozolomide.
J
Neurooncol. 2024 Jan 23;166(2):321-330. doi:
10.1007/s11060-024-04564-y. PMID:
38263486. Interventional
study. ˍ